The experimental results demonstrated that the downregulation of LILRB3 significantly inhibited the proliferative capacity of ccRCC cells, thereby confirming the promotive effect of LILRB3 on ccRCC cell proliferation in vitro. The gene discussed is LILRB3; the disease is nonpapillary renal cell carcinoma.